Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2017 5
2018 6
2019 7
2020 4
2021 6
2022 10
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Designer drugs: mechanism of action and adverse effects.
Luethi D, Liechti ME. Luethi D, et al. Arch Toxicol. 2020 Apr;94(4):1085-1133. doi: 10.1007/s00204-020-02693-7. Epub 2020 Apr 6. Arch Toxicol. 2020. PMID: 32249347 Free PMC article. Review.
SLC6 transporter oligomerization.
Jayaraman K, Das AK, Luethi D, Szöllősi D, Schütz GJ, Reith MEA, Sitte HH, Stockner T. Jayaraman K, et al. Among authors: luethi d. J Neurochem. 2021 May;157(4):919-929. doi: 10.1111/jnc.15145. Epub 2020 Aug 28. J Neurochem. 2021. PMID: 32767560 Free PMC article. Review.
Structural basis of organic cation transporter-3 inhibition.
Khanppnavar B, Maier J, Herborg F, Gradisch R, Lazzarin E, Luethi D, Yang JW, Qi C, Holy M, Jäntsch K, Kudlacek O, Schicker K, Werge T, Gether U, Stockner T, Korkhov VM, Sitte HH. Khanppnavar B, et al. Among authors: luethi d. Nat Commun. 2022 Nov 7;13(1):6714. doi: 10.1038/s41467-022-34284-8. Nat Commun. 2022. PMID: 36344565 Free PMC article.
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
Ley L, Holze F, Arikci D, Becker AM, Straumann I, Klaiber A, Coviello F, Dierbach S, Thomann J, Duthaler U, Luethi D, Varghese N, Eckert A, Liechti ME. Ley L, et al. Among authors: luethi d. Neuropsychopharmacology. 2023 Oct;48(11):1659-1667. doi: 10.1038/s41386-023-01607-2. Epub 2023 May 25. Neuropsychopharmacology. 2023. PMID: 37231080 Free PMC article. Clinical Trial.
Pharmacological profile of methylphenidate-based designer drugs.
Luethi D, Kaeser PJ, Brandt SD, Krähenbühl S, Hoener MC, Liechti ME. Luethi D, et al. Neuropharmacology. 2018 May 15;134(Pt A):133-140. doi: 10.1016/j.neuropharm.2017.08.020. Epub 2017 Aug 18. Neuropharmacology. 2018. PMID: 28823611 Free article.
Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux.
Luethi D, Maier J, Rudin D, Szöllősi D, Angenoorth TJF, Stankovic S, Schittmayer M, Burger I, Yang JW, Jaentsch K, Holy M, Das AK, Brameshuber M, Camacho-Hernandez GA, Casiraghi A, Newman AH, Kudlacek O, Birner-Gruenberger R, Stockner T, Schütz GJ, Sitte HH. Luethi D, et al. Commun Biol. 2022 Nov 17;5(1):1259. doi: 10.1038/s42003-022-04210-1. Commun Biol. 2022. PMID: 36396757 Free PMC article.
38 results